Bookmarks
UNIRAD UK Sample collection
Population Size
Not reported
Years
2015
Associated BioSamples
Availability to be confirmed
Geographic coverage
United Kingdom
England
Lead time
Other
Summary
Collection of samples and data across the following diseases: Malignant tumour of breast
Documentation
Randomised, double-blind, multicentre phase III trial evaluating the safety and benefit of adding everolimus to adjuvant hormone therapy in women with high risk of relapse, ER+ and HER2- primary breast cancer who remain free of disease (UNIRAD).
Dataset type
Health and disease
Dataset sub-type
Not applicable
Keywords
collection, Sample, UKCRC Tissue Directory, Malignant tumour of breast, UK, UNIRAD
Provenance
Image contrast
Not stated
Biological sample availability
Availability to be confirmed
Details
Publishing frequency
Other
Version
1.0.0
Modified
08/10/2024
Citation Requirements
In Progress
Coverage
Start date
01/01/2015
Time lag
Variable
Geographic coverage
United Kingdom, England
Accessibility
Language
en
Controlled vocabulary
LOCAL
Format
In Progress
Data Access Request
Dataset pipeline status
Not available
Access rights
Please contact the publisher using Contact Point details provided
Time to dataset access
Other
Access request cost
Not specified
Access method category
Varies based on project
Data Controller
Institute of Cancer Research